Cargando…

The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study

BACKGROUND: Despite the heavy burden and impact of the polycystic ovary syndrome (PCOS) in reproduction and public health, estimates regarding its prevalence at community levels are limited. We aimed to ascertain prevalence of PCOS in a community based sample using the National Institute of Health (...

Descripción completa

Detalles Bibliográficos
Autores principales: Tehrani, Fahimeh Ramezani, Simbar, Masoumeh, Tohidi, Maryam, Hosseinpanah, Farhad, Azizi, Fereidoun
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3070632/
https://www.ncbi.nlm.nih.gov/pubmed/21435276
http://dx.doi.org/10.1186/1477-7827-9-39
_version_ 1782201395827441664
author Tehrani, Fahimeh Ramezani
Simbar, Masoumeh
Tohidi, Maryam
Hosseinpanah, Farhad
Azizi, Fereidoun
author_facet Tehrani, Fahimeh Ramezani
Simbar, Masoumeh
Tohidi, Maryam
Hosseinpanah, Farhad
Azizi, Fereidoun
author_sort Tehrani, Fahimeh Ramezani
collection PubMed
description BACKGROUND: Despite the heavy burden and impact of the polycystic ovary syndrome (PCOS) in reproduction and public health, estimates regarding its prevalence at community levels are limited. We aimed to ascertain prevalence of PCOS in a community based sample using the National Institute of Health (NIH), the Rotterdam consensus (Rott.) and the Androgen Excess Society (AES) criteria. METHODS: Using the stratified, multistage probability cluster sampling method, 1126 women were randomly selected from among reproductive aged women of different geographic regions of Iran. PCOS were diagnosed using universal assessment of ultrasonographic parameters, hormonal profiles and clinical histories. RESULTS: The mean +/- SD of age of study population was 34.4 +/- 7.6 years. Estimated prevalence of idiopathic hirsutism was 10.9% (95% CI: 8.9-12.9%); 8.3% of women had only oligo/anovulation and 8.0% had only polycystic ovaries. The prevalence of PCOS was 7.1% (95% CI: 5.4-8.8%) using the NIH definition, 11.7% (95% CI: 9.5-13.7%) by AES criteria and 14.6% (95% CI: 12.3-16.9%) using the Rott definition. CONCLUSIONS: At community level, widespread screening of Rotterdam criteria will increase the estimated prevalence of PCOS over twofold. Establishing an explicit and contemporaneous method for definition and screening of each PCOS criteria has important investigational implications and increase the comparability of published research.
format Text
id pubmed-3070632
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30706322011-04-05 The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study Tehrani, Fahimeh Ramezani Simbar, Masoumeh Tohidi, Maryam Hosseinpanah, Farhad Azizi, Fereidoun Reprod Biol Endocrinol Research BACKGROUND: Despite the heavy burden and impact of the polycystic ovary syndrome (PCOS) in reproduction and public health, estimates regarding its prevalence at community levels are limited. We aimed to ascertain prevalence of PCOS in a community based sample using the National Institute of Health (NIH), the Rotterdam consensus (Rott.) and the Androgen Excess Society (AES) criteria. METHODS: Using the stratified, multistage probability cluster sampling method, 1126 women were randomly selected from among reproductive aged women of different geographic regions of Iran. PCOS were diagnosed using universal assessment of ultrasonographic parameters, hormonal profiles and clinical histories. RESULTS: The mean +/- SD of age of study population was 34.4 +/- 7.6 years. Estimated prevalence of idiopathic hirsutism was 10.9% (95% CI: 8.9-12.9%); 8.3% of women had only oligo/anovulation and 8.0% had only polycystic ovaries. The prevalence of PCOS was 7.1% (95% CI: 5.4-8.8%) using the NIH definition, 11.7% (95% CI: 9.5-13.7%) by AES criteria and 14.6% (95% CI: 12.3-16.9%) using the Rott definition. CONCLUSIONS: At community level, widespread screening of Rotterdam criteria will increase the estimated prevalence of PCOS over twofold. Establishing an explicit and contemporaneous method for definition and screening of each PCOS criteria has important investigational implications and increase the comparability of published research. BioMed Central 2011-03-25 /pmc/articles/PMC3070632/ /pubmed/21435276 http://dx.doi.org/10.1186/1477-7827-9-39 Text en Copyright ©2011 Tehrani et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Tehrani, Fahimeh Ramezani
Simbar, Masoumeh
Tohidi, Maryam
Hosseinpanah, Farhad
Azizi, Fereidoun
The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study
title The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study
title_full The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study
title_fullStr The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study
title_full_unstemmed The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study
title_short The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study
title_sort prevalence of polycystic ovary syndrome in a community sample of iranian population: iranian pcos prevalence study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3070632/
https://www.ncbi.nlm.nih.gov/pubmed/21435276
http://dx.doi.org/10.1186/1477-7827-9-39
work_keys_str_mv AT tehranifahimehramezani theprevalenceofpolycysticovarysyndromeinacommunitysampleofiranianpopulationiranianpcosprevalencestudy
AT simbarmasoumeh theprevalenceofpolycysticovarysyndromeinacommunitysampleofiranianpopulationiranianpcosprevalencestudy
AT tohidimaryam theprevalenceofpolycysticovarysyndromeinacommunitysampleofiranianpopulationiranianpcosprevalencestudy
AT hosseinpanahfarhad theprevalenceofpolycysticovarysyndromeinacommunitysampleofiranianpopulationiranianpcosprevalencestudy
AT azizifereidoun theprevalenceofpolycysticovarysyndromeinacommunitysampleofiranianpopulationiranianpcosprevalencestudy
AT tehranifahimehramezani prevalenceofpolycysticovarysyndromeinacommunitysampleofiranianpopulationiranianpcosprevalencestudy
AT simbarmasoumeh prevalenceofpolycysticovarysyndromeinacommunitysampleofiranianpopulationiranianpcosprevalencestudy
AT tohidimaryam prevalenceofpolycysticovarysyndromeinacommunitysampleofiranianpopulationiranianpcosprevalencestudy
AT hosseinpanahfarhad prevalenceofpolycysticovarysyndromeinacommunitysampleofiranianpopulationiranianpcosprevalencestudy
AT azizifereidoun prevalenceofpolycysticovarysyndromeinacommunitysampleofiranianpopulationiranianpcosprevalencestudy